J&J to Buy Aragon Pharmaceuticals for Prostate Cancer Drug

J&J to Buy Aragon Pharmaceuticals for Prostate Cancer Drug

Scott Eells/Bloomberg

Johnson & Johnson was the fastest-growing company among large pharmaceutical makers last year, buoyed by eight new medicines that generated $4.4 billion in new sales in 2012.